Regular exercise or changing diet does not influence aortic valve disease progression in ldlr deficient mice

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Schlotter, Florian ^a   Matsumoto, Yasuharu ^b   Mangner, Norman ^a   Schuler, Gerhard ^a   Linke, Axel ^a   Adams, Volker ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR; BIOLOGICAL MARKER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA FLOW; AORTA VALVE DISEASE; ARTERIAL WALL THICKNESS; ARTICLE; BODY WEIGHT; CHOLESTEROL DIET; CONTROLLED STUDY; CORONARY FLOW RESERVE; DIET; DISEASE COURSE; ENDOTHELIUM CELL; EXERCISE; FIBROBLAST; FOOD INTAKE; HISTOPATHOLOGY; INFLAMMATION; LIPID METABOLISM; MOUSE; NONHUMAN; OSTEOBLAST; OXIDATIVE STRESS; SECONDARY PREVENTION; ANIMAL; AORTA VALVE; AORTA VALVE STENOSIS; BLOOD FLOW VELOCITY; C57BL MOUSE; CALCINOSIS; GENETICS; METABOLISM; MOUSE MUTANT; PATHOLOGY; PATHOPHYSIOLOGY; VASCULAR ENDOTHELIUM;

ANIMALIA; MUS;

ANIMALS; AORTIC VALVE; AORTIC VALVE STENOSIS; BIOLOGICAL MARKERS; BLOOD FLOW VELOCITY; BODY WEIGHT; CALCINOSIS; DIET; DISEASE PROGRESSION; ENDOTHELIUM, VASCULAR; LIPID METABOLISM; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OXIDATIVE STRESS; PHYSICAL EXERTION; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, LDL; SECONDARY PREVENTION;

EID: 84861013407     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037298     Document Type: Article

References (28)

1. Beckmann E, Grau JB, Sainger R, Poggio P, Ferrari G, (2010) Insights into the use of biomarkers in calcific aortic valve disease. J Heart Valve Dis 19: 441-452.
2. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, et al. (2006) Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet 368: 1005-1011.
3. Writing Committee, Bonow RO, Carabello BA, Chatterjee K, de Leon AC, et al. (2008) 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease. Circulation 118: e523-e661.
4. Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS, (1999) Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med 341: 142-147.
5. Ben-Dor I, Pichard AD, Gonzalez MA, Weissman G, Li Y, et al. (2010) Correlates and causes of death in patients with severe symptomatic aortic stenosis who are not eligible to participate in a clinical trial of transcatheter aortic valve implantation. Circulation 122: S37-S42.
6. Roberts WC, Ko JM, (2005) Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, With or without associated aortic regurgitation. Circulation 111: 920-925.
7. Gummert JF, Funkat A, Beckmann A, Schiller W, Hekmat K, et al. (2010) Cardiac surgery in Germany during 2009. A report on behalf of the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg 58: 379-386.
8. Freeman RV, Otto CM, (2005) Spectrum of calcific aortic valve disease. Circulation 111: 3316-3326.
9. Newby DE, Cowell SJ, Boon NA, (2006) Emerging medical treatments for aortic stenosis: statins, angiotensin converting enzyme inhibitors, or both? Heart 92: 729-734.
10. Stewart BF, Siscovick D, Lind BK, Gardin JM, Gottdiener JS, et al. (1997) Clinical factors associated with calcific aortic valve disease. J Am Coll Cardiol 29: 630-634.
11. Rajamannan NM, (2009) Calcific aortic stenosis. Arterioscler Thromb Vasc Biol 29: 162-168.
12. Thompson PD, Buchner D, Pina IL, Balady GJ, Williams MA, et al. (2003) Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity). Circulation 107: 3109-3116.
13. Matsumoto Y, Adams V, Jacob S, Mangner N, Schuler G, et al. (2010) Regular exercise training prevents aortic valve disease in LDLR deficient mice. Circulation 121: 759-767.
14. Otto C, (2008) Calcified aortic stenosis - time to look more closely at the valve. N Engl J Med 359: 1395-1398.
15. Chan KL, Teo K, Dumesnil JG, Ni A, Tam J, for the ASTRONOMER Investigators, (2010) Effect of lipid lowering with rosuvastatin on progression of aortic stenosis. Circulation 121: 306-314.
16. Rossebo AB, Pedersen TR, Boman K, Brudi P, Chambers JB, et al. (2008) Intensive llipid lowering with Simvastatin and Ezetimibe in aortic stenosis. N Engl J Med 359: 1343-1356.
17. Cowell SJ, Newby DE, Prescott RJ, Bloomfield P, Reid J, et al. (2005) A Randomized Trial of Intensive Lipid-Lowering Therapy in Calcific Aortic Stenosis. N Engl J Med 352: 2389-2397.
18. Adams V, Linke A, Kränkel N, Erbs S, Gielen S, et al. (2005) Impact of regular physical activity on the NAD(P)H oxidase and angiotensin receptor system in patients with coronary artery disease. Circulation 111: 555-562.
19. Aikawa E, Nahrendorf M, Sosnovik D, Lok VM, Jaffer FA, et al. (2007) Multimodality molecular imaging identifies proteolytic and osteogenic activities in early aortic valve disease. Circulation 115: 377-386.
20. El-Hamamsy I, Balachandran K, Yacoub MH, Stevens LM, Sarathchandra P, et al. (2009) Endothelium-dependent regulation of the mechanical properties of aortic valve cusps. J Am Coll Cardiol 53: 1448-1455.
21. Yip CYY, Chen JH, Zhao R, Simmons CA, (2009) Calcification by valve interstitial cells is regulated by the stiffness of the extracellular matrix. Arterioscler Thromb Vasc Biol 29: 936-942.
22. Butcher JT, Tressel S, Johnson T, Turner D, Sorescu G, et al. (2006) Transcriptional profiles of valvular and vascular endothelial cells reveal phenotypic differences. Arterioscler Thromb Vasc Biol 26: 69-77.
23. Miller JD, Weiss RM, Serrano KM, Brooks RM, Berry CJ, et al. (2009) Lowering plasma cholesterol levels halts progression of aortic valve disease in mice. Circulation 119: 2693-2701.
24. O'Brien KD, Shavelle DM, Caulfield MT, McDonald TO, Olin-Lewis K, et al. (2002) Association of angiotensin-converting enzyme with low-density lipoprotein in aortic valvular lesions and in human plasma. Circulation 106: 2224-2230.
25. Helske S, Lindstedt KA, Laine M, Mäyränpää M, Werkkala K, et al. (2004) Induction of local angiotensin II-producing systems in stenotic aortic valves. J Am Coll Cardiol 44: 1859-1866.
26. Salas MJ, Santana O, Escolar E, Lamas GA, (2011) Medical therapy for calcific aortic stenosis. J Cardiovasc Pharmacol Aug 9 [Epub ahead of print].
27. Sider KL, Blaser MC, Simmons CA, (2011) Animal models of calcific aortic valve disease. Int J Inflam 2011 364310.
28. Miller JD, Weiss RM, Heistad DD, (2011) Calcific aortic valve stenosis: Methods, models, and mechanisms. Circ Res 108: 1392-1412.